Phase II Trial of Erlotinib plus Capecitabine as First-line Treatment for Metastatic Pancreatic Cancer (XELTA Study)

Reboredo Lopez, Margarita; Candamio Folgar, Sonia; López López, Rafael; Quintero Aldana, Guillermo; Salgado Fernández, Mercedes; De La Cámara Gómez, Juan Cruz
Thumbnail
Statistics
Statistics
Identifiers
Identifiers
URI: http://hdl.handle.net/20.500.11940/1498
PMID: 23393373
ISSN: 0250-7005
Full record
Services
Services
RISMendeleyLinksolver
Date issued
2013
Journal title
ANTICANCER RESEARCH
Type of content
Artigo